These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 20411803

  • 41. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Lindenbaum Y, Kissel JT, Mendell JR.
    Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC, Natarajan N, Ropper AH, Weinstein R.
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Immune-mediated neuropathies: pathophysiology and management].
    Tian YY, Yuan PP, Wang XG.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Sep 06; 58(9):1432-1437. PubMed ID: 39290027
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Deterioration after Guillain-Barré syndrome: recurrence, treatment-related fluctuation or CIDP?
    Hadden RD.
    J Neurol Neurosurg Psychiatry; 2009 Jan 06; 80(1):3. PubMed ID: 19091702
    [No Abstract] [Full Text] [Related]

  • 51. Therapy of CIDP and related immune-mediated neuropathies.
    Koski CL.
    Neurology; 2002 Dec 24; 59(12 Suppl 6):S22-7. PubMed ID: 12499467
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Treatment for Crow-Fukase (POEMS) syndrome].
    Kuwabara S.
    Rinsho Shinkeigaku; 2011 Nov 24; 51(11):1019. PubMed ID: 22277463
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Pathogenesis of immune-mediated neuropathies.
    Dalakas MC.
    Biochim Biophys Acta; 2015 Apr 24; 1852(4):658-66. PubMed ID: 24949885
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy.
    Mahdi-Rogers M, Kazmi M, Ferner R, Hughes RA, Renaud S, Steck AJ, Fuhr P, Halter J, Gratwohl A, Tyndall A.
    J Peripher Nerv Syst; 2009 Jun 24; 14(2):118-24. PubMed ID: 19691534
    [Abstract] [Full Text] [Related]

  • 60. Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases.
    Vital C, Vital A, Ferrer X, Viallard JF, Pellegrin JL, Bouillot S, Larrieu JM, Lequen L, Larrieu JL, Brechenmacher C, Petry KG, Lagueny A.
    J Peripher Nerv Syst; 2003 Sep 24; 8(3):136-44. PubMed ID: 12904234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.